NeoGenomics (NEO) Completes Acquisition of Pathline
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/26/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
NeoGenomics Completes Acquisition of Pathline
April 7, 2025 7:05 AM EDTPatients and physicians will benefit from access to NeoGenomics broad test menu and high-quality laboratory services in the Tri-state area
FORT MYERS, Fla.--(BUSINESS WIRE)-- NeoGenomics, Inc. (NeoGenomics or the Company) (NASDAQ: NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced... More



